152 related articles for article (PubMed ID: 22192589)
1. Pharmacophore-based discovery of a novel cytosolic phospholipase A(2)α inhibitor.
Noha SM; Jazzar B; Kuehnl S; Rollinger JM; Stuppner H; Schaible AM; Werz O; Wolber G; Schuster D
Bioorg Med Chem Lett; 2012 Jan; 22(2):1202-7. PubMed ID: 22192589
[TBL] [Abstract][Full Text] [Related]
2. Thermodynamic characterization of cytosolic phospholipase A2 alpha inhibitors.
Ramarao MK; Shen MW; Murphy EA; Duan W; Zhao Y; McKew J; Lee KL; Thakker P; Behnke ML; Clark JD
Anal Biochem; 2008 Dec; 383(2):217-25. PubMed ID: 18801329
[TBL] [Abstract][Full Text] [Related]
3. C2-di-ethyl-ceramide-1-phosphate as an inhibitor of group IVA cytosolic phospholipase A2.
Makiyama T; Nakamura H; Nishida A; Murayama T
Eur J Pharmacol; 2012 Dec; 697(1-3):144-51. PubMed ID: 23043861
[TBL] [Abstract][Full Text] [Related]
4. 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
Forster L; Ludwig J; Kaptur M; Bovens S; Elfringhoff AS; Holtfrerich A; Lehr M
Bioorg Med Chem; 2010 Jan; 18(2):945-52. PubMed ID: 20005725
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of 3-pyrrol-3-yl-3H-isobenzofuran-1-ones as inhibitors of human cytosolic phospholipase A2alpha.
Hess M; Schulze Elfringhoff A; Lehr M
J Enzyme Inhib Med Chem; 2008 Dec; 23(6):946-57. PubMed ID: 18608744
[TBL] [Abstract][Full Text] [Related]
6. 1-(2-Carboxyindol-5-yloxy)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis, biological activity, metabolic stability, and solubility.
Fritsche A; Elfringhoff AS; Fabian J; Lehr M
Bioorg Med Chem; 2008 Apr; 16(7):3489-500. PubMed ID: 18321717
[TBL] [Abstract][Full Text] [Related]
7. Group IVA cytosolic phospholipase A2 (cPLA2alpha) and integrin alphaIIbbeta3 reinforce each other's functions during alphaIIbbeta3 signaling in platelets.
Prévost N; Mitsios JV; Kato H; Burke JE; Dennis EA; Shimizu T; Shattil SJ
Blood; 2009 Jan; 113(2):447-57. PubMed ID: 18840708
[TBL] [Abstract][Full Text] [Related]
8. Interfacial kinetic and binding properties of mammalian group IVB phospholipase A2 (cPLA2beta) and comparison with the other cPLA2 isoforms.
Ghomashchi F; Naika GS; Bollinger JG; Aloulou A; Lehr M; Leslie CC; Gelb MH
J Biol Chem; 2010 Nov; 285(46):36100-11. PubMed ID: 20705608
[TBL] [Abstract][Full Text] [Related]
9. Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors.
Bononi G; Granchi C; Lapillo M; Giannotti M; Nieri D; Fortunato S; Boustani ME; Caligiuri I; Poli G; Carlson KE; Kim SH; Macchia M; Martinelli A; Rizzolio F; Chicca A; Katzenellenbogen JA; Minutolo F; Tuccinardi T
Eur J Med Chem; 2018 Sep; 157():817-836. PubMed ID: 30144699
[TBL] [Abstract][Full Text] [Related]
10. Cytosolic phospholipase A2 alpha inhibition prevents neuronal NMDA receptor-stimulated arachidonic acid mobilization and prostaglandin production but not subsequent cell death.
Taylor AL; Bonventre JV; Uliasz TF; Hewett JA; Hewett SJ
J Neurochem; 2008 Aug; 106(4):1828-40. PubMed ID: 18564366
[TBL] [Abstract][Full Text] [Related]
11. (E)-Phenyl- and -heteroaryl-substituted O-benzoyl-(or acyl)oximes as lipoprotein-associated phospholipase A2 inhibitors.
Jeong TS; Kim MJ; Yu H; Kim KS; Choi JK; Kim SS; Lee WS
Bioorg Med Chem Lett; 2005 Mar; 15(5):1525-7. PubMed ID: 15713421
[TBL] [Abstract][Full Text] [Related]
12. 2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity.
Antonopoulou G; Magrioti V; Kokotou MG; Nikolaou A; Barbayianni E; Mouchlis VD; Dennis EA; Kokotos G
Bioorg Med Chem; 2016 Oct; 24(19):4544-4554. PubMed ID: 27522578
[TBL] [Abstract][Full Text] [Related]
13. Cytosolic phospholipase A(2)α protects against Fas- but not LPS-induced liver injury.
Li G; Chen W; Han C; Wu T
J Hepatol; 2011 Dec; 55(6):1281-90. PubMed ID: 21703211
[TBL] [Abstract][Full Text] [Related]
14. Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs.
Thakker P; Marusic S; Stedman NL; Lee KL; McKew JC; Wood A; Goldman SJ; Leach MW; Collins M; Kuchroo VK; Wolf SF; Clark JD; Hassan-Zahraee M
J Immunol; 2011 Aug; 187(4):1986-97. PubMed ID: 21746963
[TBL] [Abstract][Full Text] [Related]
15. TLR4-dependent induction of vascular adhesion molecule-1 in rheumatoid arthritis synovial fibroblasts: Roles of cytosolic phospholipase A(2)alpha/cyclooxygenase-2.
Wu CY; Chi PL; Hsieh HL; Luo SF; Yang CM
J Cell Physiol; 2010 May; 223(2):480-91. PubMed ID: 20112284
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of 1-indol-1-yl-propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha.
Ludwig J; Bovens S; Brauch C; Elfringhoff AS; Lehr M
J Med Chem; 2006 Apr; 49(8):2611-20. PubMed ID: 16610804
[TBL] [Abstract][Full Text] [Related]
17. Benzhydrylquinazolinediones: novel cytosolic phospholipase A2alpha inhibitors with improved physicochemical properties.
Kirincich SJ; Xiang J; Green N; Tam S; Yang HY; Shim J; Shen MW; Clark JD; McKew JC
Bioorg Med Chem; 2009 Jul; 17(13):4383-405. PubMed ID: 19482480
[TBL] [Abstract][Full Text] [Related]
18. Cytosolic phospholipase A2alpha activation induced by S1P is mediated by the S1P3 receptor in lung epithelial cells.
Chen LY; Woszczek G; Nagineni S; Logun C; Shelhamer JH
Am J Physiol Lung Cell Mol Physiol; 2008 Aug; 295(2):L326-35. PubMed ID: 18502815
[TBL] [Abstract][Full Text] [Related]
19. 1-(5-Carboxyindazol-1-yl)propan-2-ones as dual inhibitors of cytosolic phospholipase A
Althaus J; Hake T; Hanekamp W; Lehr M
J Enzyme Inhib Med Chem; 2016; 31(sup1):131-140. PubMed ID: 27162011
[TBL] [Abstract][Full Text] [Related]
20. Binding conformation of 2-oxoamide inhibitors to group IVA cytosolic phospholipase A2 determined by molecular docking combined with molecular dynamics.
Mouchlis VD; Michopoulou V; Constantinou-Kokotou V; Mavromoustakos T; Dennis EA; Kokotos G
J Chem Inf Model; 2012 Jan; 52(1):243-54. PubMed ID: 22196172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
